Icade S.A. | Large-cap | Real Estate
€21.76
0.46%
| Icade S.A Stock Comparison:
Icade S.A vs Eurobio ScientificIcade S.A vs Affluent MedicalIcade S.A vs Carmat S.AIcade S.A vs Median TechnologiesIcade S.A vs Novacyt S.AIcade S.A vs CAC 40 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.5B
Gross Profit 501.8M 34.57%
Operating Income 212.2M 14.62%
Net Income -317.2M -21.85%
EPS (Diluted) -€3.64

Balance Sheet Metrics

Total Assets 10.5B
Total Liabilities 6.2B
Shareholders Equity 4.4B
Debt to Equity 1.41

Cash Flow Metrics

Operating Cash Flow -137.0M
Free Cash Flow 166.2M

Revenue & Profitability Trend

Icade S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue1.5B1.5B1.6B1.7B1.4B
Cost of Goods Sold949.8M946.1M861.1M753.2M615.8M
Gross Profit501.8M581.5M707.4M907.7M824.4M
Operating Expenses249.9M286.7M246.7M378.2M218.8M
Operating Income212.2M257.6M291.2M605.0M555.2M
Pre-tax Income-343.3M-1.3B-180.3M644.8M188.9M
Income Tax-26.7M-9.2M22.2M8.4M5.2M
Net Income-317.2M-1.3B221.9M637.0M186.7M
EPS (Diluted)-€3.64-€16.50€0.71€5.33€1.07

Income Statement Trend

Icade S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets4.0B4.6B2.8B2.1B2.4B
Non-Current Assets6.5B7.0B15.4B15.5B14.8B
Total Assets10.5B11.6B18.2B17.6B17.2B
Liabilities
Current Liabilities2.2B1.9B2.5B2.3B2.4B
Non-Current Liabilities4.0B4.7B7.0B6.7B6.6B
Total Liabilities6.2B6.5B9.5B9.0B9.0B
Equity
Total Shareholders Equity4.4B5.1B8.7B8.6B8.2B

Balance Sheet Composition

Icade S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income-317.2M-1.3B221.9M637.0M186.7M
Operating Cash Flow-137.0M-1.3B140.6M771.4M483.5M
Investing Activities
Capital Expenditures-----
Investing Cash Flow-9.0M1.2B1.5M-427.7M-48.0M
Financing Activities
Dividends Paid-366.7M-328.1M-317.8M-196.1M-296.5M
Financing Cash Flow-582.7M-770.6M124.3M-135.6M414.5M
Free Cash Flow166.2M3.6M-234.2M-497.6M119.5M

Cash Flow Trend

Icade S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 45.49
Forward P/E 6.90
Price to Book 0.41
Price to Sales 1.27
PEG Ratio 6.90

Profitability Ratios

Profit Margin -19.54%
Operating Margin 16.90%
Return on Equity -6.72%
Return on Assets 0.98%

Financial Health

Current Ratio 1.84
Debt to Equity 108.60
Beta 1.31

Per Share Data

EPS (TTM) -€3.63
Book Value per Share €57.05
Revenue per Share €18.64

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
icad1.8B45.490.41-6.72%-19.54%108.60
Eurobio Scientific 253.4M64.741.422.26%2.58%5.46
Affluent Medical 53.3M-3.551.73-48.69%-275.50%0.54
Carmat S.A 24.8M--100.52%-336.56%-1.13
Median Technologies 25.6M-1.02-74.31%-109.93%-0.98
Novacyt S.A 34.9M-0.820.72-57.28%-212.73%24.81

Financial data is updated regularly. All figures are in the company's reporting currency.